5-(3-(2-cyclopropoxypyridin-4-yl)-5-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yloxy)-2-methylpentan-2-ol

ID: ALA4764221

PubChem CID: 162661098

Max Phase: Preclinical

Molecular Formula: C24H28N6O3

Molecular Weight: 448.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2nc3c(-c4ccnc(OC5CC5)c4)cnn3cc2OCCCC(C)(C)O)cn1

Standard InChI:  InChI=1S/C24H28N6O3/c1-24(2,31)8-4-10-32-20-15-30-23(28-22(20)17-12-26-29(3)14-17)19(13-27-30)16-7-9-25-21(11-16)33-18-5-6-18/h7,9,11-15,18,31H,4-6,8,10H2,1-3H3

Standard InChI Key:  YFUNSPWUHJGDOO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   20.0167  -24.0151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4978  -23.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0163  -22.6906    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2680  -24.7908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7196  -25.3982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9718  -26.1747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7595  -26.3533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.3194  -25.7327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0643  -24.9585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2381  -23.7624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2387  -22.9397    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5305  -22.5302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8172  -22.9387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8166  -23.7613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5293  -24.1754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1092  -24.1686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3632  -23.8349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8153  -24.4412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2227  -25.1497    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0223  -24.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0028  -24.3544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4208  -26.7783    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.6227  -26.6030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0174  -26.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8421  -26.8531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1104  -22.5286    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1121  -21.7114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4053  -21.3013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4070  -20.4841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7002  -20.0740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7019  -19.2568    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9916  -20.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1180  -19.4888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10  1  2  0
  1  2  1  0
  2  3  2  0
  3 11  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  1  4  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 14 16  1  0
 18 21  1  0
  6 22  1  0
 22 23  1  0
 24 23  1  0
 25 24  1  0
 23 25  1  0
 13 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 30 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4764221

    ---

Associated Targets(Human)

TGFBR2 Tchem TGF-beta receptor type II (795 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACVR2A Tchem Activin receptor type-2A (326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.53Molecular Weight (Monoisotopic): 448.2223AlogP: 3.66#Rotatable Bonds: 9
Polar Surface Area: 99.59Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.03CX LogP: 2.87CX LogD: 2.87
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -0.91

References

1. Miwa S,Yokota M,Ueyama Y,Maeda K,Ogoshi Y,Seki N,Ogawa N,Nishihata J,Nomura A,Adachi T,Kitao Y,Nozawa K,Ishikawa T,Ukaji Y,Shiozaki M.  (2021)  Discovery of Selective Transforming Growth Factor β Type II Receptor Inhibitors as Antifibrosis Agents.,  12  (5.0): [PMID:34055221] [10.1021/acsmedchemlett.0c00679]

Source